16 studies were found.

1.		Recruiting	Decitabine versus Supportive Care in Adults with Advanced-stage MDS Condition: Myelodysplastic Syndrome
2.		Recruiting	Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD Condition: Acute Graft Versus Host Disease
3.		No longer recruiting	Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer Conditions: recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
4.		No longer recruiting	Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas Conditions: recurrent pancreatic cancer; adenocarcinoma of the pancreas
5.		No longer recruiting	Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer Conditions: recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
6.		No longer recruiting	Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery Conditions: stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
7.		Completed	Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer
8.		Completed	Nitrocamptothecin in Treating Patients With Metastatic Melanoma Conditions: Stage IV Melanoma; Recurrent Melanoma
9.		Completed	Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer Condition: recurrent non-small cell lung cancer
10.		Completed	Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas Conditions: stage IVB adult soft tissue sarcoma; childhood leiomyosarcoma; recurrent childhood soft tissue sarcoma; gastrointestinal stromal tumor; ...
11.		No longer recruiting	Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer Conditions: recurrent pancreatic cancer; adenocarcinoma of the pancreas
12.		Recruiting	Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes Conditions: Leukemia; Myelodysplastic Syndromes
13.		Recruiting	Phase II Randomized Study of three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS) Conditions: Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia
14.		Recruiting	Phase II trial of decitabine in patients with chronic myelogenous leukemia accelerated phase who are refractory to imatinib mesylate (Gleevec) Condition: Chronic Myelogenous Leukemia
15.		Recruiting	Phase II trial of decitabine in patients with chronic myelogenous leukemia blast phase who are refractory to imatinib mesylate (Gleevec) Condition: Chronic Myelogenous Leukemia
16.		Recruiting	Phase II trial of decitabine in patients with chronic myelogenous leukemia chronic phase who are refractory to imatinib mesylate (Gleevec) Condition: Chronic Myelogenous Leukemia